Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 210

Investors transfer $135m to Remitly

Prudential Financial and existing shareholder PayU have backed a $135m series E round for Remitly, which concurrently obtained $85m in debt financing.

Jul 10, 2019

IGM Biosciences amasses $102m series C

Haldor Topsøe has returned to participate in a $102m series C round for the cancer treatment developer.

Jul 10, 2019

The future for $100m rounds and the innovation economy

It has been a remarkable decade for innovation capital. More than $1 trillion of venture capital had been invested by the end of last year, according to data provider Pitchbook, driven by corporations engaging in more than half that total, according to GCV Analytics.

Jul 10, 2019

Analysis: Carbon prints out another funding round

3D printing developer Carbon raised a new round reaching $260m and featuring corporate backers from different sectors.

Jul 8, 2019

Tier IV tears it up to raise $105m

Sompo Japan Nipponkoa led the Utec-backed autonomous vehicle software developer's series A round, which included Yamaha Motor, Aisan Technology and existing investor KDDI.

Jul 4, 2019

Tier IV tears it up to raise $105m

Sompo Japan Nipponkoa led the autonomous vehicle software developer's series A round, which included Yamaha Motor, Aisan Technology and existing investor KDDI.

Jul 4, 2019

Calm arcs series B round to $115m

Mindfulness app developer Calm has added $27m to its series B round, after receiving an initial $88m tranche from investors including CAA five months ago.

Jul 4, 2019

MX Player looks to record $100m investment

Tencent and Paytm are considering a $100m investment in MX Player, a video streaming service majority owned by Times Internet.

Jul 3, 2019

ReNew Power investors return with $300m

Jera-backed solar and wind power developer ReNew Power has secured three $100m commitments by existing investors Goldman Sachs, ADIA and Canada Pension Plan Investment Board.

Jul 3, 2019

Bayer leads Century to $250m

Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having been established by Versant Ventures to advance Stanford and Harvard research.

Jul 2, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here